136 related articles for article (PubMed ID: 37681974)
1. Dysregulated pulmonary inflammatory responses exacerbate the outcome of secondary aspergillosis following influenza.
Lee CK; Oliveira LVN; Akalin A; Specht CA; Lourenco D; Gomez CL; Ramirez-Ortiz ZG; Wang JP; Levitz SM
mBio; 2023 Oct; 14(5):e0163323. PubMed ID: 37681974
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated Pulmonary Inflammatory Responses Exacerbate the Outcome of Secondary Aspergillosis Following Influenza.
Lee CK; Oliveira LVN; Akalin A; Specht CA; Lourenco D; Gomez CL; Ramirez-Ortiz ZG; Wang JP; Levitz SM
bioRxiv; 2023 Jun; ():. PubMed ID: 37425745
[TBL] [Abstract][Full Text] [Related]
3. Postinfluenza Environment Reduces Aspergillus fumigatus Conidium Clearance and Facilitates Invasive Aspergillosis
Liu KW; Grau MS; Jones JT; Wang X; Vesely EM; James MR; Gutierrez-Perez C; Cramer RA; Obar JJ
mBio; 2022 Dec; 13(6):e0285422. PubMed ID: 36377895
[TBL] [Abstract][Full Text] [Related]
4. Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model.
Seldeslachts L; Vanderbeke L; Fremau A; Reséndiz-Sharpe A; Jacobs C; Laeveren B; Ostyn T; Naesens L; Brock M; Van De Veerdonk FL; Humblet-Baron S; Verbeken E; Lagrou K; Wauters J; Vande Velde G
Virulence; 2021 Dec; 12(1):2493-2508. PubMed ID: 34546839
[TBL] [Abstract][Full Text] [Related]
5. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
[TBL] [Abstract][Full Text] [Related]
6. Influenza Suppresses Neutrophil Recruitment to the Lung and Exacerbates Secondary Invasive Pulmonary Aspergillosis.
Tobin JM; Nickolich KL; Ramanan K; Pilewski MJ; Lamens KD; Alcorn JF; Robinson KM
J Immunol; 2020 Jul; 205(2):480-488. PubMed ID: 32522833
[No Abstract] [Full Text] [Related]
7. Development of a Corticosteroid-Immunosuppressed Mouse Model to Study the Pathogenesis and Therapy of Influenza-Associated Pulmonary Aspergillosis.
Wurster S; Pantaleón García J; Albert ND; Jiang Y; Bhoda K; Kulkarni VV; Wang Y; Walsh TJ; Evans S; Kontoyiannis DP
J Infect Dis; 2023 Apr; 227(7):901-906. PubMed ID: 36611269
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and outcomes of influenza-associated pulmonary aspergillosis among critically ill patients: a systematic review and meta-analysis.
Chong WH; Saha BK; Tan CK
J Hosp Infect; 2022 Feb; 120():98-109. PubMed ID: 34843812
[TBL] [Abstract][Full Text] [Related]
9. Three-Dimensional Light Sheet Fluorescence Microscopy of Lungs To Dissect Local Host Immune-Aspergillus fumigatus Interactions.
Amich J; Mokhtari Z; Strobel M; Vialetto E; Sheta D; Yu Y; Hartweg J; Kalleda N; Jarick KJ; Brede C; Jordán-Garrote AL; Thusek S; Schmiedgen K; Arslan B; Pinnecker J; Thornton CR; Gunzer M; Krappmann S; Einsele H; Heinze KG; Beilhack A
mBio; 2020 Feb; 11(1):. PubMed ID: 32019790
[No Abstract] [Full Text] [Related]
10. [Invasive pulmonary aspergillosis in influenza].
Kolwijck E; Scheper H; Beuving J; Kuijper EJ; van der Hoeven JG; Verweij PE
Ned Tijdschr Geneeskd; 2015; 159():A7431. PubMed ID: 25714763
[TBL] [Abstract][Full Text] [Related]
11. CD11b Regulates Fungal Outgrowth but Not Neutrophil Recruitment in a Mouse Model of Invasive Pulmonary Aspergillosis.
Teschner D; Cholaszczyńska A; Ries F; Beckert H; Theobald M; Grabbe S; Radsak M; Bros M
Front Immunol; 2019; 10():123. PubMed ID: 30778357
[TBL] [Abstract][Full Text] [Related]
12. Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.
Zhao J; Zhuo X; Pu D; Fan G; Lu B; Cao B
Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):683-692. PubMed ID: 38326545
[TBL] [Abstract][Full Text] [Related]
13. Neuroimmune Responses in a New Experimental Animal Model of Cerebral Aspergillosis.
Sullivan BN; Baggett MA; Guillory C; Jones M; Steele C
mBio; 2022 Oct; 13(5):e0225422. PubMed ID: 36040029
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, Risk Factors, Clinical Features, and Outcome of Influenza-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Systematic Review and Meta-Analysis.
Lu LY; Lee HM; Burke A; Li Bassi G; Torres A; Fraser JF; Fanning JP
Chest; 2024 Mar; 165(3):540-558. PubMed ID: 37742914
[TBL] [Abstract][Full Text] [Related]
15. Chronic ethanol consumption compromises neutrophil function in acute pulmonary
Malacco NLSO; Souza JAM; Martins FRB; Rachid MA; Simplicio JA; Tirapelli CR; Sabino AP; Queiroz-Junior CM; Goes GR; Vieira LQ; Souza DG; Pinho V; Teixeira MM; Soriani FM
Elife; 2020 Jul; 9():. PubMed ID: 32701055
[TBL] [Abstract][Full Text] [Related]
16. Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis.
Dewi IMW; Cunha C; Jaeger M; Gresnigt MS; Gkountzinopoulou ME; Garishah FM; Duarte-Oliveira C; Campos CF; Vanderbeke L; Sharpe AR; Brüggemann RJ; Verweij PE; Lagrou K; Vande Velde G; de Mast Q; Joosten LAB; Netea MG; van der Ven AJAM; Wauters J; Carvalho A; van de Veerdonk FL
Cell Rep Med; 2021 May; 2(5):100289. PubMed ID: 34095887
[TBL] [Abstract][Full Text] [Related]
17. Overcome Double Trouble: Baloxavir Marboxil Suppresses Influenza Thereby Mitigating Secondary Invasive Pulmonary Aspergillosis.
Seldeslachts L; Jacobs C; Tielemans B; Vanhoffelen E; Van der Sloten L; Humblet-Baron S; Naesens L; Lagrou K; Verbeken E; Wauters J; Vande Velde G
J Fungi (Basel); 2021 Dec; 8(1):. PubMed ID: 35049941
[TBL] [Abstract][Full Text] [Related]
18. Higher risk for influenza-associated pulmonary aspergillosis (IAPA) in asthmatic patients: A Swiss multicenter cohort study on IAPA in critically ill influenza patients.
Waldeck F; Boroli F; Zingg S; Walti LN; Wendel-Garcia PD; Conen A; Pagani JL; Boggian K; Schnorf M; Siegemund M; Abed-Maillard S; Michot M; Que YA; Bättig V; Suh N; Kleger GR; Albrich WC
Influenza Other Respir Viruses; 2023 Jan; 17(1):e13059. PubMed ID: 36394086
[TBL] [Abstract][Full Text] [Related]
19. Influenza-associated invasive aspergillosis in patients admitted to the intensive care unit in Sweden: a prospective multicentre cohort study.
Krifors A; Blennow O; Påhlman LI; Gille-Johnson P; Janols H; Lipcsey M; Källman J; Tham J; Stjärne Aspelund A; Ljungquist O; Hammarskjöld F; Hällgren A; De Geer L; Lemberg M; Petersson J; Castegren M
Infect Dis (Lond); 2024 Feb; 56(2):110-115. PubMed ID: 37897800
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Evaluation of Recombinant Microbial Glycoside Hydrolases in the Prevention of Experimental Invasive Aspergillosis.
Ostapska H; Raju D; Lehoux M; Lacdao I; Gilbert S; Sivarajah P; Bamford NC; Baker P; Nguyen TTM; Zacharias CA; Gravelat FN; Howell PL; Sheppard DC
mBio; 2021 Oct; 12(5):e0244621. PubMed ID: 34579578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
